These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4062317)

  • 1. [Enhancing activity of bacterial preparations on blood flow in tumor tissue, with reference to cancer chemotherapy. Experimental and clinical studies].
    Kudo T; Abo S; Itabashi T; Onodera K; Shikama T; Hashimoto M; Kawamura Y; Tsuji K; Watanabe K; Ikeda T
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2166-71. PubMed ID: 4062317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Continuous measurement of tumor blood flow under hypertension induced by angiotensin II--clinical studies with laser Doppler velocimetry].
    Kudo T; Abo S; Itabashi T; Watanabe K; Onodera K; Shimoma N; Kawamura Y; Hashimoto M; Kato T; Watanabe K
    Gan To Kagaku Ryoho; 1986 Aug; 13(8):2549-54. PubMed ID: 2943227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of OK-432 in the treatment of primary lung cancer].
    Kishimoto T; Okada K
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1051-6. PubMed ID: 3494430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The Su-polysaccharide skin test in lung cancer].
    Harada J; Horiguchi T; Oki K; Miyamoto H; Osada T
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2697-702. PubMed ID: 3307634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of Su-polysaccharide (Su-PS) skin test in patients with primary lung cancer treated with chemotherapy and administration of OK-432, with special reference to the therapeutic effect and prognosis].
    Horiuchi M; Sato K; Nakarai I; Shinoda A
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 2):468-74. PubMed ID: 2181937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of immune skin reactions in progressive lung cancer during the administration of OK-432--relation to reactions to DNCB, PPD and Su-PS].
    Katada H; Nishikawa K; Yoneda T; Kitamura H; Nakajima A; Mikami R
    Gan To Kagaku Ryoho; 1987 Jan; 14(1):61-70. PubMed ID: 3026256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of a skin test (SU-PS) for immune responses in patients with gastrointestinal cancer treated with OK-432].
    Miyamoto Y; Takeshita M; Izuo M
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3229-35. PubMed ID: 3777960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relation between prognosis and the Su-PS skin reaction in patients with non-resected primary lung cancer receiving OK-432].
    Nakarai I; Rikitake H; Koga T; Hayashi A; Harada Y; Takamoto M; Ishibashi T; Shinoda A; Sagawa K
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3050-7. PubMed ID: 2823723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and experimental studies on a new intrabronchial infusion therapy of immunopotentiator-OK-432 in lung cancer].
    Gose K; Hirota S; Imajo Y; Adachi S; Yonezawa K; Soejima T; Takada Y; Kimura S; Tsubota N
    Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1208-16. PubMed ID: 3782973
    [No Abstract]   [Full Text] [Related]  

  • 10. [Randomized controlled study of OK-432 in the treatment of cancerous pleurisy].
    Urata A; Nishimura M; Ota K
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1497-503. PubMed ID: 6409006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Induction of the human tumor necrosis factor (h-TNF) by the streptococcal preparation, OK-432--a clinical trial in 10 lung cancer patients with pleural fluid].
    Miyai M; Matsuka Y; Tsubota T; Asano K
    Nihon Gan Chiryo Gakkai Shi; 1986 Jul; 21(6):1285-91. PubMed ID: 3782979
    [No Abstract]   [Full Text] [Related]  

  • 12. [Adjuvant immunochemotherapy with long-term OK-432 administration in colorectal cancer].
    Kikkawa N; Sasai H; Kawahara T
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2163-9. PubMed ID: 6486832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
    Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Studies on the enhancement of anti-tumor activity in patients with cervical cancer by local administration of OK-432].
    Yamada Y; Yamamoto K; Wakita K; Shiraki S; Noda K
    Gan To Kagaku Ryoho; 1986 Dec; 13(12):3427-31. PubMed ID: 3789753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel method for mapping the heterogeneity in blood supply to normal and malignant tissues in the mouse dorsal window chamber.
    Øye KS; Gulati G; Graff BA; Gaustad JV; Brurberg KG; Rofstad EK
    Microvasc Res; 2008 Mar; 75(2):179-87. PubMed ID: 17688890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Skin reaction to OK-432 and its dosage for locoregional administration].
    Yamaguchi Y; Noma K; Miyahara E; Funakoshi M; Takashima I; Kawami H; Sawamura A; Toge T
    Gan To Kagaku Ryoho; 1994 Sep; 21(13):2108-10. PubMed ID: 7944414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of toll-like receptor 4 on dendritic cells is significant for anticancer effect of dendritic cell-based immunotherapy in combination with an active component of OK-432, a streptococcal preparation.
    Okamoto M; Furuichi S; Nishioka Y; Oshikawa T; Tano T; Ahmed SU; Takeda K; Akira S; Ryoma Y; Moriya Y; Saito M; Sone S; Sato M
    Cancer Res; 2004 Aug; 64(15):5461-70. PubMed ID: 15289356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combined treatment with radiotherapy and Streptococcus hemolyticus (OK-432) (author's transl)].
    Tsujii H; Mizoe J; Arimoto T
    Nihon Gan Chiryo Gakkai Shi; 1978 Oct; 13(5):560-6. PubMed ID: 722143
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunotherapy of terminal-stage malignant tumors with the immunopotentiator OK-432--a comparison between SU-PS test-responder and -nonresponder patients].
    Yagi Y; Yagi S; Ichiki H
    Gan No Rinsho; 1987 Jun; 33(7):815-21. PubMed ID: 3302349
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrocardiogram studies on cancer patients treated with OK-432, a streptococcal preparation with potent biological response modifier activities.
    Torisu M; Goya T; Hayashi Y; Tanaka J; Sugisaki T; Yoshida T
    J Biol Response Mod; 1989 Dec; 8(6):665-75. PubMed ID: 2689599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.